Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study

The cases of bacterial multidrug resistance are increasing every year and becoming a serious concern for human health. Multidrug efflux pumps are key players in the formation of antibiotic resistance, which transfer out a broad spectrum of drugs from the cell and convey resistance to the host. Efflux pumps have significantly reduced the efficacy of the previously available antibiotic armory, thereby increasing the frequency of therapeutic failures. In gram-negative bacteria, the AcrAB-TolC efflux pump is the principal transporter of the substrate and plays a major role in the formation of antibiotic resistance. In the current work, advanced computer-aided drug discovery approaches were utilized to find hit molecules from the library of biogenic chalcones against the bacterial AcrB efflux pump. The results of the performed computational studies via molecular docking, drug-likeness prediction, pharmacokinetic profiling, pharmacophore mapping, density functional theory, and molecular dynamics simulation study provided ZINC000004695648, ZINC000014762506, ZINC000014762510, ZINC000095099506, and ZINC000085510993 as stable hit molecules against the AcrB efflux pumps. Identified hits could successfully act against AcrB efflux pumps after optimization as lead molecules.Communicated by Ramaswamy H. Sarma.

[1]  P. Choudhari,et al.  Exploration of limonoids for their broad spectrum antiviral potential via DFT, molecular docking and molecular dynamics simulation approach. , 2023, Natural product research.

[2]  Pralhad K. Mudalkar,et al.  Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach , 2023, Journal of Molecular Modeling.

[3]  C. Supuran,et al.  Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids , 2023, ACS omega.

[4]  P. Choudhari,et al.  Exploration of bioactive molecules from Tinospora cordifolia and Actinidia deliciosa as an immunity modulator via molecular docking and molecular dynamics simulation study. , 2023, Natural product research.

[5]  A. Al‐Sehemi,et al.  Computational Exploration of Anti-cancer Potential of Flavonoids against Cyclin-Dependent Kinase 8: An In Silico Molecular Docking and Dynamic Approach , 2022, ACS omega.

[6]  R. Gaikwad,et al.  In-silico Study of Phytoconstituents from Tribulus terrestris as potential Anti-psoriatic agent , 2022, Asian Journal of Pharmaceutical Research.

[7]  Rawaf Alenazy Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli , 2022, Biology.

[8]  Janaína Esmeraldo Rocha,et al.  Antibacterial and antibiotic modifying activity of chalcone (2E)-1-(4'-aminophenyl)-3-(4-methoxyphenyl)-prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps: In vitro and in silico approaches. , 2022, Microbial pathogenesis.

[9]  Ibrahim M. Ibrahim,et al.  Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects , 2022, Molecules.

[10]  C. H. D. da Silva,et al.  Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents , 2022, Frontiers in Molecular Biosciences.

[11]  A. Al‐Sehemi,et al.  In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2 , 2022, Journal of Saudi Chemical Society.

[12]  K. Ilango,et al.  Computer Aided Drug Design Approach to Screen Phytoconstituents of Adhatoda vasica as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme , 2022, Life.

[13]  J. Rocha,et al.  In vitro and in silico studies of chalcones derived from natural acetophenone inhibitors of NorA and MepA multidrug efflux pumps in Staphylococcus aureus. , 2021, Microbial pathogenesis.

[14]  M. Abdalla,et al.  Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties , 2021, Computers in Biology and Medicine.

[15]  Tingjun Hou,et al.  The impact of cross-docked poses on performance of machine learning classifier for protein–ligand binding pose prediction , 2021, Journal of Cheminformatics.

[16]  L. Nahar,et al.  Chalcones: Synthetic Chemistry Follows Where Nature Leads , 2021, Biomolecules.

[17]  Bo Zheng,et al.  Combating antibiotic resistance: current strategies for the discovery of novel antibacterial materials based on macrocycle supramolecular chemistry , 2021, Giant.

[18]  A. Al‐Sehemi,et al.  Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro , 2021, Journal of biomolecular structure & dynamics.

[19]  S. Mouneir,et al.  Synthesis, DFT calculation, pharmacological evaluation, and catalytic application in the synthesis of diverse pyrano[2,3-c]pyrazole derivatives. , 2021, Bioorganic chemistry.

[20]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[21]  Yang Ouyang,et al.  Chalcone Derivatives: Role in Anticancer Therapy , 2021, Biomolecules.

[22]  J. Rocha,et al.  Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2-hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  F. Baquero,et al.  Antibiotic resistance: Time of synthesis in a post-genomic age , 2021, Computational and structural biotechnology journal.

[24]  J. S. Rana,et al.  Antibiotic resistance in agriculture: Perspectives on upcoming strategies to overcome upsurge in resistance , 2021, Current research in microbial sciences.

[25]  P. Rekha,et al.  A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India , 2021, Scientific Reports.

[26]  J. Rocha,et al.  Structural characterization, DFT calculations, ADMET studies, antibiotic potentiating activity, evaluation of efflux pump inhibition and molecular docking of chalcone (E)-1-(2-hydroxy-3,4,6-trimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one , 2021, Journal of Molecular Structure.

[27]  R. Forgione,et al.  Understanding the Antibacterial Resistance: Computational Explorations in Bacterial Membranes , 2021, ACS omega.

[28]  R. Kasimanickam,et al.  Antibiotics Use in Food Animal Production: Escalation of Antimicrobial Resistance: Where Are We Now in Combating AMR? , 2021, Medical sciences.

[29]  Tugba G. Kucukkal,et al.  Computational Chemistry Activities with Avogadro and ORCA , 2021 .

[30]  B. Salehi,et al.  Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence , 2021, Frontiers in Pharmacology.

[31]  P. Singh,et al.  Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? , 2020, Expert opinion on drug metabolism & toxicology.

[32]  P. Higgins,et al.  Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump , 2020, PloS one.

[33]  P. Matczak,et al.  A DFT study on the mechanism of the formation of 1,4,2,3‐dithiadiazinanes by head‐to‐head [3 + 3] cyclodimerization of thiocarbonyl S ‐imides , 2020 .

[34]  Andy M. Lau,et al.  Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB , 2020, Nature Communications.

[35]  Shivanika C,et al.  Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease , 2020, Journal of biomolecular structure & dynamics.

[36]  J. Rocha,et al.  Potentiation of antibiotic activity by chalcone (E)-1-(4'-aminophenyl)-3-(furan-2-yl)-prop-2-en-1-one against gram-positive and gram-negative MDR strains. , 2020, Microbial pathogenesis.

[37]  A. Al‐Sehemi,et al.  Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis , 2020, Journal of biomolecular structure & dynamics.

[38]  M. A. Alam,et al.  DFT studies on vibrational and electronic spectra, HOMO–LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene)hydrazinecarbodithioate , 2020, Journal of Molecular Structure.

[39]  Eric R. Geertsma,et al.  AcrB: a mean, keen, drug efflux machine , 2020, Annals of the New York Academy of Sciences.

[40]  P. K. Patial,et al.  Phytochemical profile, antioxidant potential and DFT study of Araucaria columnaris (G. Forst.) Hook. Branch extracts , 2019, Natural product research.

[41]  M. Diederich,et al.  Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology. , 2019, European journal of medicinal chemistry.

[42]  B. Wilkinson,et al.  Antibiotics: past, present and future. , 2019, Current opinion in microbiology.

[43]  T. M. Belete Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents , 2019, Human Microbiome Journal.

[44]  Y. Lim,et al.  Resveratrol controls Escherichia coli growth by inhibiting the AcrAB‐TolC efflux pump , 2019, FEMS microbiology letters.

[45]  Yanfei Gao,et al.  Enhanced strength–ductility synergy in ultrafine-grained eutectic high-entropy alloys by inheriting microstructural lamellae , 2019, Nature Communications.

[46]  R. Lamuela-Raventós,et al.  In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice. , 2019, Journal of natural products.

[47]  Sakshi Singh,et al.  Identification of small molecule activators for ErbB 4 receptor to enhance oligodendrocyte regeneration by in silico approach , 2018, Computational Toxicology.

[48]  T. Kausar,et al.  Identification of small molecule inhibitors of ALK2: a virtual screening, density functional theory, and molecular dynamics simulations study , 2018, Journal of Molecular Modeling.

[49]  W. Reygaert An overview of the antimicrobial resistance mechanisms of bacteria , 2018, AIMS microbiology.

[50]  David Ramírez,et al.  Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? , 2018, Molecules.

[51]  V. Saini,et al.  Design, synthesis, DFT, docking studies and ADME prediction of some new coumarinyl linked pyrazolylthiazoles: Potential standalone or adjuvant antimicrobial agents , 2018, PloS one.

[52]  I. Nambi,et al.  Antibiotic usage, residues and resistance genes from food animals to human and environment: An Indian scenario , 2018 .

[53]  D. Chatterji,et al.  Antibiotic Resistance: Current Perspectives , 2017, ACS omega.

[54]  G. Bloom,et al.  Antimicrobial resistance and universal health coverage , 2017, BMJ Global Health.

[55]  S. Chakraborty,et al.  Accelerated Healing of Diabetic Wounds Treated with L-Glutamic acid Loaded Hydrogels Through Enhanced Collagen Deposition and Angiogenesis: An In Vivo Study , 2017, Scientific Reports.

[56]  Eugene N. Muratov,et al.  Chalcone Derivatives: Promising Starting Points for Drug Design , 2017, Molecules.

[57]  R. Melander,et al.  The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach? , 2017, ACS infectious diseases.

[58]  C. Xing,et al.  Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.

[59]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[60]  Lina Ding,et al.  Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations. , 2016, Journal of ethnopharmacology.

[61]  R. Bonomo,et al.  Overview: Global and Local Impact of Antibiotic Resistance. , 2016, Infectious disease clinics of North America.

[62]  Ruth Huey,et al.  Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.

[63]  P. Perjési,et al.  Naturally occurring chalcones and their biological activities , 2016, Phytochemistry Reviews.

[64]  Vivek Asati,et al.  Anti-cancer chalcones: Structural and molecular target perspectives. , 2015, European journal of medicinal chemistry.

[65]  M. Martins,et al.  The ins and outs of RND efflux pumps in Escherichia coli , 2015, Front. Microbiol..

[66]  H. Venter,et al.  RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition , 2015, Front. Microbiol..

[67]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[68]  Yu-chian Chen Beware of docking! , 2015, Trends in pharmacological sciences.

[69]  A. Yan,et al.  Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. , 2014, Biochemical and biophysical research communications.

[70]  C. Xing,et al.  Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice , 2014, Chemical research in toxicology.

[71]  Wah Chiu,et al.  Structure of the AcrAB-TolC multidrug efflux pump , 2014, Nature.

[72]  Hong Wan,et al.  What ADME tests should be conducted for preclinical studies , 2013 .

[73]  J. Bartlett,et al.  Seven ways to preserve the miracle of antibiotics. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  Attilio V Vargiu,et al.  Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations , 2012, Proceedings of the National Academy of Sciences.

[75]  K. Diederichs,et al.  Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop , 2012, Proceedings of the National Academy of Sciences.

[76]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[77]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[78]  M. Diederich,et al.  Dietary chalcones with chemopreventive and chemotherapeutic potential , 2011, Genes & Nutrition.

[79]  B. Bandgar,et al.  Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents. , 2010, Bioorganic & medicinal chemistry.

[80]  Ricardo L. Mancera,et al.  Ligand-Protein Cross-Docking with Water Molecules , 2010, J. Chem. Inf. Model..

[81]  Ruth Nussinov,et al.  Novel Approach for Efficient Pharmacophore-Based Virtual Screening: Method and Applications , 2009, J. Chem. Inf. Model..

[82]  K. M. Pos Drug transport mechanism of the AcrB efflux pump. , 2009, Biochimica et biophysica acta.

[83]  Ruth Nussinov,et al.  PharmaGist: a webserver for ligand-based pharmacophore detection , 2008, Nucleic Acids Res..

[84]  Ruth Nussinov,et al.  Deterministic Pharmacophore Detection Via Multiple Flexible Alignment of Drug-Like Molecules , 2007, RECOMB.

[85]  J. Sikorski,et al.  Recent advances in therapeutic chalcones , 2004 .

[86]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[87]  Satoshi Murakami,et al.  Crystal structure of bacterial multidrug efflux transporter AcrB , 2002, Nature.

[88]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[89]  R. Srivastava,et al.  Identification of novel anti-cryptosporidial inhibitors through a combined approach of pharmacophore modeling, virtual screening, and molecular docking , 2021 .

[90]  W. Witte,et al.  Antibiotic resistance. , 2013, International journal of medical microbiology : IJMM.

[91]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[92]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[93]  J. Molnár,et al.  Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them , 2014, Front. Pharmacol..